Where I see patients (2)
My reviews
Selected research
-
Poor melanoma outcomes and survival in Asian American and Pacific Islander patients.
Journal of the American Academy of Dermatology
-
A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600E/K mutant advanced melanoma.
Pigment cell & melanoma research
-
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.
Oncotarget
4.9